about
Advances and Challenges in Studying Hepatitis B Virus In VitroBiocompatible Hydrogels for Microarray Cell Printing and Encapsulation.Evaluation of database-derived pathway development for enabling biomarker discovery for hepatotoxicityA Liver-Centric Multiscale Modeling Framework for XenobioticsAdvances in Engineered Liver Models for Investigating Drug-Induced Liver InjuryComparative gene expression profiles induced by PPARγ and PPARα/γ agonists in human hepatocytesMicromechanical control of cell-cell interactions.Determination of rat hepatocellular glutathione by reversed-phase liquid chromatography with fluorescence detection and cytotoxicity evaluation of environmental pollutants based on the concentration change.Expression and induction of a large set of drug-metabolizing enzymes by the highly differentiated human hepatoma cell line BC2.Genome-wide estimation of gender differences in the gene expression of human livers: statistical design and analysis.Development and utilization of primary hepatocyte culture systems to evaluate metabolism, DNA binding, and DNA repair of xenobiotics.Liver tissue engineering in the evaluation of drug safety.Micropatterned cell-cell interactions enable functional encapsulation of primary hepatocytes in hydrogel microtissues.Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems.In vitro platforms for evaluating liver toxicity.Gene Expression Changes Induced by PPAR Gamma Agonists in Animal and Human Liver.Protective effect of bixin on carbon tetrachloride-induced hepatotoxicity in rats.Tissue-level modeling of xenobiotic metabolism in liver: An emerging tool for enabling clinical translational researchFrom whole body to cellular models of hepatic triglyceride metabolism: man has got to know his limitationsInteractions between the cytochrome P450 system and the second-generation antipsychotics.Long-term coculture strategies for primary hepatocytes and liver sinusoidal endothelial cellsA study of the mechanism of in vitro cytotoxicity of metal oxide nanoparticles using catfish primary hepatocytes and human HepG2 cells.2-Amino-9H-pyrido[2,3-b]indole (AαC) Adducts and Thiol Oxidation of Serum Albumin as Potential Biomarkers of Tobacco SmokeMicroengineered cell and tissue systems for drug screening and toxicology applications: Evolution of in-vitro liver technologies.In vitro-in vivo translation of lipid nanoparticles for hepatocellular siRNA delivery.Scaffolds for liver tissue engineering.Involvement of cell junctions in hepatocyte culture functionality.In vitro models for liver toxicity testing.T-cadherin modulates hepatocyte functions in vitro.Fibrogenesis of parenchymal organs.Human skin-derived stem cells as a novel cell source for in vitro hepatotoxicity screening of pharmaceuticals.Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells.Evaluation of in vitro assays for assessing the toxicity of cigarette smoke and smokeless tobacco.Engineering a perfusable 3D human liver platform from iPS cells.Integrating in vitro organ-specific function with the microcirculation.Three-dimensional culture of hepatocytes for prediction of drug-induced hepatotoxicity.Primary hepatocyte cultures as prominent in vitro tools to study hepatic drug transporters.Liver tissue engineering and cell sources: issues and challenges.Pluripotent stem cell-derived hepatocyte-like cells.Cell and tissue engineering for liver disease.
P2860
Q26771134-29BB7E87-7EE5-4CB5-B3A3-DD06414D4E17Q26777809-53279F4B-F2D3-41AE-9E5C-32D3AB4D136CQ27027301-315FC07D-C773-4E86-8B2B-96A567435A54Q27323311-4690F918-E392-4209-A696-BE75AC1B5339Q28077505-6D9A1F17-45A7-44AA-9535-9864A14DC1D3Q28477796-92436CAD-C248-4051-B291-64218E016184Q30479257-EB0E1EE6-BDCA-4683-9213-60AB12616512Q30686905-F2AA76D5-0F9F-4BAF-ADB5-3CCE91A085E2Q32081610-35E47676-8FEA-4466-A42C-5CF0A16D6CC0Q33219776-0493311D-5359-4886-9183-BA0935450CCEQ33859473-A58A6E22-5DF1-4FDC-9901-2FF6160F85C0Q33950022-79041C89-E235-40F3-B164-A88317D1C795Q34063544-76C02E49-DCA8-4111-AA86-4873FA0BAA26Q34082747-FABC9CD7-2AB2-491D-99B1-439963CE5D2EQ34143314-1EE941CA-8B92-4A2E-98E7-84A5E61381F6Q34235817-806C49E7-880D-4014-BBA2-7D4927102C63Q34318543-616EEFE8-83F4-4BCE-814C-8B96C14A4676Q34746268-6192D27E-A4D8-4D21-99FD-A4BC9F1434DAQ34800989-D004ECCD-F70E-4C92-8C13-56A2079F7296Q35096587-AE3D02C6-4500-44CF-A127-704A2806E3F0Q35246486-C16801E1-ED01-4E1D-8FED-C3841ED8CB0BQ35256567-F94C7339-4EB0-4A8F-9929-678B518164AEQ35783148-44193EB1-806B-4D16-B225-53DFB06A6C04Q35826421-7C418141-45A0-4DE0-B4BB-79F90BFC0EFEQ36195057-ED2F9249-2C03-40CF-BE65-4A4380BB3615Q36344068-D653B04D-C756-4993-87AF-E8BBFC0B2701Q36523471-496EB4CB-9156-4BC5-A107-04741E81CAA7Q36671339-4BC13D11-7AA9-45E1-A3BE-BB1111F1A7E0Q36951000-3849D515-88F7-4AC1-9FDD-F5ED169EECEBQ37134952-D13382E8-C113-4FBE-8E45-D0B81025FDCFQ37409080-AC5106D9-126B-4C87-A115-08BCEA04FEB6Q37428266-C7B3E391-F6D2-45A4-8376-38FF90014A6CQ37461637-E5A80090-933A-45BD-9DE8-86861A5E0570Q37655140-5DC26C1F-A2F4-4220-98BF-EB5904D92173Q37691970-D4C81261-910F-4B9D-BAC4-44B086B082E8Q37727962-EABF387B-828F-49E6-A4AD-4AEE29FA8C53Q38077993-AF6F4DC3-41CE-4392-BEE5-672E8F3AF67CQ38089346-A99ECD5A-5F5B-456B-A59A-0ECFEB3F963BQ38179753-5E1612BD-2591-4344-A1DD-FD52F1932A90Q38230357-2CB489A8-1B76-4F5C-A5F7-E85D479F2D65
P2860
description
1998 nî lūn-bûn
@nan
1998 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
name
Liver cell models in in vitro toxicology.
@ast
Liver cell models in in vitro toxicology.
@en
Liver cell models in in vitro toxicology.
@nl
type
label
Liver cell models in in vitro toxicology.
@ast
Liver cell models in in vitro toxicology.
@en
Liver cell models in in vitro toxicology.
@nl
prefLabel
Liver cell models in in vitro toxicology.
@ast
Liver cell models in in vitro toxicology.
@en
Liver cell models in in vitro toxicology.
@nl
P2860
P921
P356
P1476
Liver cell models in in vitro toxicology.
@en
P2093
Guillouzo A
P2860
P304
P356
10.1289/EHP.98106511
P478
106 Suppl 2
P577
1998-04-01T00:00:00Z